Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets

Lancet

Volumn 363, Issue 9427, 2004, Pages 2139-2141

  Ter Meulen, Jan ^a   Bakker, Alexander B H ^a   Van Den Brink, Edward N ^a   Weverling, Gerrit J ^a   Martina, Byron E E ^e   Haagmans, Bart L ^e   Kuiken, Thijs ^e   De Kruif, John ^a   Preiser, Wolfgang ^b   Spaan, Willy ^d   Gelderblom, Hans R ^c   Goudsmit, Jaap ^a   Osterhaus, Albert D M E ^e  

^a CRUCELL HOLLAND BV   (Netherlands)

^b GOETHE UNIVERSITY   (Germany)

^c ROBERT KOCH INSTITUTE   (Germany)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CR3014; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONAVIRUS; DRUG POTENCY; DRUG SCREENING; EMBRYO; FEMALE; FERRET; HUMAN; HUMAN CELL; INFECTION PREVENTION; LUNG DISEASE; NONHUMAN; PRIORITY JOURNAL; SEVERE ACUTE RESPIRATORY SYNDROME; THROAT CULTURE; VIRUS REPLICATION; VIRUS SHEDDING;

EID: 3042606257     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16506-9     Document Type: Article

References (5)

1. Guan Y, Zheng BJ, He YQ, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China. Science. 302:2003;276-278
2. Subbarao K, McAuliffe J, Vogel L, et al. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J Virol. 78:2004;3572-3577
3. Martina BE, Haagmans BL, Kuiken T, et al. SARS virus infection in cats and ferrets. Nature. 425:2003;915
4. Tsang OT, Chau TN, Choi KW, et al. Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality. Emerg Inf Dis. 9:2003;1381-1387
5. Parnes C, Guillermin J, Habersang R, et al. Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from The Palivizumab Outcomes Registry. Pediatr Pulmonol. 35:2003;484-489